Patents Assigned to Yeda Research and Developent Co., Ltd. at the Weizman Institute of Science
  • DIASTEREOMERIC PEPTIDES FOR MODULATING T CELL IMMUNITY
    Publication number: 20090275503
    Abstract: The present invention provides diastereomeric peptides derived from the T Cell Receptor alpha Transmembrane Domain, and lipophilic conjugates thereof, which peptides and conjugates are effective in preventing or treating T cell mediated inflammatory diseases. The invention provides pharmaceutical compositions comprising these diastereomeric peptides and conjugates, and uses thereof for therapy of inflammatory diseases, autoimmunity and graft rejection.
    Type: Application
    Filed: September 21, 2006
    Publication date: November 5, 2009
    Applicant: Yeda Research and Developent Co., Ltd. at the Weizman Institute of Science
    Inventors: Yechiel Shai, Irun R. Cohen, Francisco Quintana, Doron Gerber